Global Remicade Biosimilar Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI619686
- March 18, 2019
- Global
- 97 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Remicade Biosimilar market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Remicade Biosimilar market."
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
The global Remicade Biosimilar market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Remicade Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Remicade Biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Segment by Regions
North America
Europe
China
Japan
Segment by Type
100mg/10ml
500mg/50ml
Segment by Application
Blood Disorders
Oncology Diseases
Table of Contents
Executive Summary
1 Remicade Biosimilar Market Overview
1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type
1.2.1 Global Remicade Biosimilar Production Growth Rate Comparison by Type (2014-2025)
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Remicade Biosimilar Segment by Application
1.3.1 Remicade Biosimilar Consumption Comparison by Application (2014-2025)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Global Remicade Biosimilar Market by Region
1.4.1 Global Remicade Biosimilar Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Remicade Biosimilar Market Size
1.5.1 Global Remicade Biosimilar Revenue (2014-2025)
1.5.2 Global Remicade Biosimilar Production (2014-2025)
2 Global Remicade Biosimilar Market Competition by Manufacturers
2.1 Global Remicade Biosimilar Production Market Share by Manufacturers (2014-2019)
2.2 Global Remicade Biosimilar Revenue Share by Manufacturers (2014-2019)
2.3 Global Remicade Biosimilar Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Remicade Biosimilar Production Sites, Area Served, Product Types
2.5 Remicade Biosimilar Market Competitive Situation and Trends
2.5.1 Remicade Biosimilar Market Concentration Rate
2.5.2 Remicade Biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Remicade Biosimilar Production Market Share by Regions
3.1 Global Remicade Biosimilar Production Market Share by Regions
3.2 Global Remicade Biosimilar Revenue Market Share by Regions (2014-2019)
3.3 Global Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Remicade Biosimilar Production
3.4.1 North America Remicade Biosimilar Production Growth Rate (2014-2019)
3.4.2 North America Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Remicade Biosimilar Production
3.5.1 Europe Remicade Biosimilar Production Growth Rate (2014-2019)
...
| read more...
Related Reports
